Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
4.54%Stock Based Compensation Margin
VS
Market
Sector
Industry
History
$ 4.66Close
$ 2.07 - $ 7.08 52-Week Range
Ticker Information
Ticker
EVOKCompany Name
EVOKE PHARMA INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQEVOKE PHARMA INC - Stock Based Compensation Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
EVOK - SB Comp % Historical data
| Date | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
|---|---|---|---|
| 6/30/2025 | $ 12.79M | $ 581.15K | 4.54% |
| 3/31/2025 | $ 11.59M | $ 603.48K | 5.21% |
| 12/31/2024 | $ 10.25M | $ 773.12K | 7.54% |
| 9/30/2024 | $ 8.62M | $ 793.83K | 9.21% |
| 6/30/2024 | $ 7.53M | $ 944K | 12.54% |
| 3/31/2024 | $ 6.11M | $ 1.1M | 17.98% |
| 12/31/2023 | $ 5.18M | $ 1.13M | 21.78% |
| 9/30/2023 | $ 4.3M | $ 1.2M | 27.93% |
| 6/30/2023 | $ 3.57M | $ 1.28M | 35.72% |
| 3/31/2023 | $ 2.9M | $ 1.36M | 46.96% |
Key Performance Insights, Last 5 Years
- EVOKE PHARMA INC's latest trailing twelve months (TTM) SB Comp % stands at 0%.
- Over the past 5 years, EVOKE PHARMA INC's average SB Comp % has been 527.91%.
- The median SB Comp % for EVOKE PHARMA INC during this period was 46.96%
- EVOKE PHARMA INC reached its highest SB Comp % over the past 5 years at 7074.54%.
- The lowest SB Comp % recorded by EVOKE PHARMA INC in the same timeframe 4.54%
EVOKE PHARMA INC's SB Comp % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp % Benchmarks
Similar metrics to SB Comp %:
- Stock Based Compensation - [Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
Definition of Stock Based Compensation Margin
[Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].SB Comp. / Revenues
(=) SB Comp % SB Comp % for EVOKE PHARMA INC is calculated as follows: SB Comp. [ $ 1.47M ] / Revenues [ $ 0 ]
(=) SB Comp % [ 0% ] EVOK - Stock Based Compensation Margin, Last 5 years
4.54%
Minimum
Jun 30, 2025
7074.54%
Maximum
Dec 31, 2020
527.91%
Average
46.96%
Median
SB Comp % Benchmark AnalysisMarket
The chart above depicts the distribution of SB Comp % for companies in the Total Stock Market. The average SB Comp % of the companies is 1.72% with a standard deviation of 1.9%.
The following table provides additional summary stats:
SB Comp % in the Market:
| filtered constituents | 2.98K |
|---|---|
| min | -3.97% |
| max | 8.43% |
| average | 1.72% |
| median | 1.04% |
| std | 1.9% |